Valcrest Pharmaceuticals Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $50K
Latest Deal Amount

Valcrest Pharmaceuticals General Information


Developer of pharmaceutical products for treating ultra-rare orphan diseases. The company specializes in the development and commercialization of pharmaceutical products to address the needs of patients with ultra-rare orphan diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Primary Office
  • 809-B Cuesta Drive
  • Suite 196
  • Mountain View, CA 94040
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valcrest Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 27-Mar-2015 $50K 0000 Completed Startup
To view Valcrest Pharmaceuticals’s complete valuation and funding history, request access »

Valcrest Pharmaceuticals Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of pharmaceutical products for treating ultra-rare orphan diseases. The company specializes in the development
Mountain View, CA
0000000000 0000


velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
Maple Grove, MN
0.000 0000-00-00

000000 0

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
Barcelona, Spain
0000 As of 0000
000000000 00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Valcrest Pharmaceuticals Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Upsher-Smith Laboratories Corporate Backed or Acquired Maple Grove, MN 000000&0
000000 00000000000 Private Debt Financed Barcelona, Spain 0000 000000000 00
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000 0000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00000 000000&0 00000
You’re viewing 5 of 29 competitors. Get the full list »

Valcrest Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Kenneth Greathouse Chief Executive Officer
Brian Smith President and Manager
To view Valcrest Pharmaceuticals’s complete executive team members history, request access »